A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio Atla, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,659,589 shares of BCAB stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,659,589
Previous 1,649,262 61.26%
Holding current value
$1.65 Million
Previous $2.26 Million 107.17%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.17 - $2.05 $1.18 Million - $2.07 Million
1,010,327 Added 61.26%
2,659,589 $4.68 Million
Q2 2024

Aug 14, 2024

BUY
$1.37 - $3.92 $1.06 Million - $3.04 Million
775,608 Added 88.78%
1,649,262 $2.26 Million
Q1 2024

May 15, 2024

BUY
$1.88 - $3.46 $1.23 Million - $2.27 Million
654,854 Added 299.29%
873,654 $3.01 Million
Q4 2023

Feb 14, 2024

SELL
$1.27 - $3.18 $84,175 - $210,770
-66,280 Reduced 23.25%
218,800 $538,000
Q2 2023

Aug 14, 2023

BUY
$2.83 - $3.87 $286,942 - $392,390
101,393 Added 55.2%
285,080 $855,000
Q1 2023

May 15, 2023

BUY
$2.3 - $8.25 $187,730 - $673,381
81,622 Added 79.97%
183,687 $492,000
Q4 2022

Feb 14, 2023

BUY
$6.29 - $11.01 $445,218 - $779,309
70,782 Added 226.26%
102,065 $842,000
Q3 2022

Nov 14, 2022

SELL
$2.94 - $11.87 $429,316 - $1.73 Million
-146,026 Reduced 82.36%
31,283 $241,000

Others Institutions Holding BCAB

About BioAtla, Inc.


  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $22.5M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.